Japan’s health ministry has approved Leqembi, a drug for Alzheimer’s decease that was jointly developed by Japanese and U.S. pharmaceutical companies.
Kishida has pledged to step up support for the growing number of dementia patients and their families and is due to launch a panel this week to discuss measures for a dementia-friendly society.
The drug, however, does not work for everyone and — as with other Alzheimer’s drugs that target plaques in the brain — can cause dangerous side effects such as brain swelling and bleeding in rare cases.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Japan’s Suzuki: Japan at a critical stage whether to spur consumption, wage growth“Japan at a critical stage whether to spur consumption or wage growth,” Japanese Finance Minister Shunichi Suzuki said on Tuesday. Suzuki added that i
Baca lebih lajut »
Japan’s PM Kishida: To instruct ministers to compile economic package on TuesdayJapanese Prime Minister (PM) Fumio Kishida said on Monday that he will instruct ministers to compile an economic package on Tuesday. Additional quotes
Baca lebih lajut »
Verstappen win in Japan secures Red Bull sixth teams' titleRed Bull Racing's Max Verstappen dominated the 2023 F1 Japanese Grand Prix while McLaren took the second and third spots.
Baca lebih lajut »
Honda Accord with refreshed interior shown in JapanThe Japanese Accord is on a different product lifecycle and timeline than the U.S. car, so it could be awhile before the changes make it here.
Baca lebih lajut »
Japan to Kenya: the Biggest Hotel Launches This FallThe latest debuts put an emphasis on place and experience, from historic building conversions to tents in wildlife sanctuaries
Baca lebih lajut »